Recent News
Follow Up Care for Mesothelioma
Follow-up care is crucial for treating mesothelioma patients. A study out of the United Kingdom found that when patients receive follow-up care, more input from their caregivers, continuity, and more[…]
SQAP Used Alongside Radiation to Treat Mesothelioma
A chemical that makes cancer cells more sensitive to radiation could potentially help patients with mesothelioma. Radiotherapy utilizes ionizing radiation to damage the DNA of cancer cells, which affects their[…]
Researchers Could Target Neuron Cells to Fight Mesothelioma
Researchers have potentially found a new way to treat cancer by targeting nerve cells. Researchers at Technion, the Israel Institute of Technology, conducted the study that is now published in[…]
Quinacrine Combined with Cisplatin Can Help Fight Mesothelioma Cancer Cells
Mesothelioma patients with a gene mutation could benefit greatly from using an anti-malaria drug called quinacrine. Quinacrine is known by the brand name Atabrine. For a long time, it was[…]
Patients with Mesothelioma Don’t Always Have Access to the Best Care
Unfortunately, there is a lack of equality when it comes to treating mesothelioma patients because access to care can be very inconsistent. Patients might not have access to a high-volume[…]
A Cancer Fighting Gel Can Help Mesothelioma Patients
A cancer fighting gel that is applied directly to tumors could help mesothelioma patients. Researchers in Maryland tested the treatment on animals with mesothelioma tumors. The tumors responded even after[…]
MRIs vs CT Scans for Imaging Mesothelioma
MRI scans could be better than CT scans for diagnosing and monitoring disease response in pleural mesothelioma patients. An Italian study is looking at the two imaging techniques to compare[…]
Ramucirumab and Gemcitabine are Showing Promising Results as a Second Line Treatment for Pleural Mesothelioma
Combining the drug ramucirumab with the chemotherapy drug gemcitabine is showing to be a successful second line treatment for pleural mesothelioma. Ramucirumab is a type of immunotherapy drug called a[…]
Mesothelioma Patient Health Improves a Year After Surgery
It could take time for mesothelioma patients to have better lung function after pleural mesothelioma surgery since some patients have better lung function a year after surgery compared to the[…]
Tremelimumab and Durvalumab are a Good Second Line Treatment for Mesothelioma
Two immunotherapy drugs, tremelimumab and durvalumab, are showing to be a successful second line treatment for pleural mesothelioma when combined. This could mean that more treatments will be approved for[…]
Skip to content